| Title: | Association of Prediagnostic Serum Levels of Vitamin D with Risk of Ductal Carcinoma In Situ of the Breast in the UK Biobank Cohort Study. |
| Journal: | Cancer Epidemiology Biomarkers & Prevention |
| Published: | 18 Apr 2022 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/35437601/ |
| DOI: | https://doi.org/10.1158/1055-9965.epi-22-0017 |
| Citations: | 2 (1 in last 2 years) as of 8 Aug 2024 |
Publication 7150
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BACKGROUND: Higher circulating levels of vitamin D [25(OH)D] have been associated with reduced risk of developing invasive breast cancer. However, their association with risk of ductal carcinoma in situ (DCIS) of the breast has received little attention. METHODS: We examined the association of serum vitamin D with risk of DCIS in 231,203 women, aged 40 to 69 years at enrollment in the UK Biobank cohort study. Multivariable Cox proportional hazards models were used to estimate HRs and 95% confidence intervals for the association of vitamin D with DCIS risk. RESULTS: There was no association between serum 25(OH)D levels and risk of DCIS overall, or by menopausal status. The association was not modified by body mass index category, family history of breast cancer, or current use of menopausal hormone therapy. CONCLUSIONS: In this large prospective cohort study, we did not observe an association between circulating serum levels of vitamin D and risk of DCIS. IMPACT: While previous studies have suggested that serum vitamin D has an inverse association with risk of invasive breast cancer, the present results do not provide evidence for an association with DCIS, a non-obligate precursor of invasive disease.2 Authors
- Rita Peila
- Thomas E Rohan
Enabling scientific discoveries that improve human health